References
- KnowlesSR , KeeferL , WildingH , HewittC , GraffLA , Mikocka-WalusA. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses – part II. Inflamm. Bowel Dis.24, 966–976 (2018).
- MitropoulouM-A , FradelosEC , LeeKYet al.Quality of life in patients with inflammatory bowel disease: importance of psychological symptoms. Cureus14, e28502 (2022).
- KhaliliH , EverhovÅH , HalfvarsonJet al.Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden. Aliment. Pharmacol. Ther.52, 655–668 (2020).
- BassiA , DoddS , WilliamsonP , BodgerK. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut53, 1471–1478 (2004).
- TopalF , CamyarH , SaritasYuksel E , GunayS , TopalF , GürEÖ. Work productivity loss in inflammatory bowel disease patients in Turkey. Gastroenterol. Res. Pract.2020, 6979720 (2020).
- CrossRK , SaukJS , ZhuoJet al.Poor patient-reported outcomes and impaired work productivity in patients with inflammatory bowel disease in remission. Gastro Hep Adv.1, 927–935 (2022).
- AvitanAK , SchwartzD , GreenbergDet al.The impact of inflammatory bowel disease on work productivity: comparison of a real-world sample of patients with Crohn's disease and ulcerative colitis. Value Health19, A511 (2016).
- MayberryJF. Impact of inflammatory bowel disease on educational achievements and work prospects. J. Pediatr. Gastroenterol. Nutr.28, S34–S36 (1999).
- CalsbeekH , RijkenM , DekkerJ , vanBerge Henegouwen GP. Disease characteristics as determinants of the labour market position of adolescents and young adults with chronic digestive disorders. Eur. J. Gastroenterol. Hepatol.18, 203–209 (2006).
- LönnforsS , VermeireS , GrecoM , HommesD , BellC , AvedanoL. IBD and health-related quality of life - discovering the true impact. J. Crohns Colitis8, 1281–1286 (2014).
- van GennepS , EversSW , RietdijkSTet al.High disease burden drives indirect costs in employed inflammatory bowel disease patients: the WORK-IBD study. Inflamm. Bowel Dis.27, 352–363 (2021).
- BernklevT , JahnsenJ , HenriksenMet al.Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm. Bowel Dis.12, 402–412 (2006).
- vander Valk ME , MangenM-JJ , LeendersMet al.Risk factors of work disability in patients with inflammatory bowel disease – a Dutch nationwide web-based survey: work disability in inflammatory bowel disease. J. Crohns Colitis8, 590–597 (2014).
- SiebertU , WurmJ , GotheRMet al.Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflamm. Bowel Dis.19, 847–855 (2013).
- vander Have M , BrakenhoffLKPM , van ErpSJHet al.Back/joint pain, illness perceptions and coping are important predictors of quality of life and work productivity in patients with inflammatory bowel disease: a 12-month longitudinal study. J. Crohns Colitis9, 276–283 (2015).
- ReillyMC , GerlierL , BrabantY , BrownM. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease. Clin. Ther.30, 393–404 (2008).
- YarlasA , MaherSM , BaylissMS , LovleyA , CappelleriJC , DiBonaventuraMD. Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review. J. Patient Rep Outcomes2, 62 (2018).
- ReillyMC , ZbrozekAS , DukesEM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics4, 353–365 (1993).
- ZandA , van DeenWK , InserraEKet al.Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact. Inflamm. Bowel Dis.21, 1623–1630 (2015).
- FairbrassKM , CostantinoSJ , GracieDJ , FordAC. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol.5, 1053–1062 (2020).
- MancinaRM , PagnottaR , PagliusoCet al.Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: a nursing-led cross-sectional study of patients in clinical remission. Medicina (Mex)56, 45 (2020).
- LouisE , LöfbergR , ReinischWet al.Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial. J. Crohns Colitis7, 34–43 (2013).
- PanaccioneR , LoftusEVJr , BinionDet al.Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian subjects with moderate to severe Crohn's disease (ACCESS) trial. Can. J. Gastroenterol.25(8), 419–425 (2011).
- LichtigerS , BinionDG , WolfDCet al.The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy. Aliment. Pharmacol. Ther.32(10), 1228–1239 (2010).
- LeBerre C , Peyrin-BirouletL , BuissonAet al.Impact of inflammatory bowel diseases on working life: a French nationwide survey. Dig. Liver Dis.51, 961–966 (2019).
- TestaA , RispoA , RomanoMet al.The burden of anaemia in patients with inflammatory bowel diseases. Dig. Liver Dis.48, 267–270 (2016).